DONGKOOK PHARM revenue for the last year amounted to 731.00 B KRW, the most of which — 740.09 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 675.32 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought DONGKOOK PHARM 659.13 B KRW, and the year before that — 593.76 B KRW.